Business
Empower Psychedelics is raising awareness for physical fitness as a key component of therapeutic recovery and rehabilitation...
What investors need to know about the intellectual property behind medicine’s next big growth area...
Math over Myth is your weekly source for psychedelic stock updates, including Compass Pathways and Revive Therapeutics...
Math over Myth is your weekly update on psychedelic stocks and ETFs, including ATAI, COMPASS, Cybin, GH Research, Mindset, Numinus,...
Get the latest news on psychedelic stocks Cybin, Numinus, MindMed, ATAI, Mindset, Braxia, Tryp, Irwin Naturals, and Revive...
Track the monthly performance of the psychedelic stock sector with our Math over Myth Stock News Roundup...
Psychedelic stock MindMed enters free fall as news of a private equity offering of common stock spooks retail investors...
The psychedelic corporate shakeout continues as another company, HAVN Life Sciences, folds due to lack of cash flow...
We interview Dr. Paul Thielking, Chief Science Officer of Numinus, about the use of psychedelics in palliative care and end...
In the latest installment of Math Over Myth we navigate psychedelic stock MindMed’s reverse split with Fibonacci numbers...